Tandem Diabetes Care Stock Market Value

TNDM Stock  USD 27.58  0.95  3.57%   
Tandem Diabetes' market value is the price at which a share of Tandem Diabetes stock trades on a public exchange. It measures the collective expectations of Tandem Diabetes Care investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Tandem Diabetes Care and determine expected loss or profit from investing in Tandem Diabetes over a given investment horizon.
Check out Tandem Diabetes Correlation, Tandem Diabetes Volatility and Tandem Diabetes Alpha and Beta module to complement your research on Tandem Diabetes.

Tandem Diabetes Care Valuation

Is Tandem Diabetes' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tandem Diabetes 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tandem Diabetes' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tandem Diabetes.
No Change 0.00  0.0 
In 31 days
If you would invest  0.00  in Tandem Diabetes on February 1, 2024 and sell it all today you would earn a total of 0.00 from holding Tandem Diabetes Care or generate 0.0% return on investment in Tandem Diabetes over 30 days. Tandem Diabetes is related to or competes with Veeva Systems, Mednax, Doximity, Laboratory, Cigna Corp, Definitive Healthcare, and Guardant Health. Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people ... More

Tandem Diabetes Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tandem Diabetes' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tandem Diabetes Care upside and downside potential and time the market with a certain degree of confidence.

Tandem Diabetes Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Tandem Diabetes' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tandem Diabetes' standard deviation. In reality, there are many statistical measures that can use Tandem Diabetes historical prices to predict the future Tandem Diabetes' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Tandem Diabetes' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Tandem Diabetes in the context of predictive analytics.
17 Analysts
Estimates (0)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tandem Diabetes. Your research has to be compared to or analyzed against Tandem Diabetes' peers to derive any actionable benefits. When done correctly, Tandem Diabetes' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tandem Diabetes Care.

Tandem Diabetes Care Backtested Returns

Tandem Diabetes appears to be not too volatile, given 3 months investment horizon. Tandem Diabetes Care owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had 0.12% return per unit of risk over the last 3 months. Our standpoint towards measuring the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By inspecting Tandem Diabetes Care technical indicators you can presently evaluate if the expected return of 0.52% is justified by implied risk. Please review Tandem Diabetes' Coefficient Of Variation of 674.81, semi deviation of 2.56, and Risk Adjusted Performance of 0.1022 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tandem Diabetes holds a performance score of 9. The entity has a beta of 2.42, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tandem Diabetes will likely underperform. We have found twenty-nine technical indicators for Tandem Diabetes Care, which you can use to evaluate the performance of the company. Please operates Tandem Diabetes value at risk, as well as the relationship between the skewness and day median price to make a quick decision on whether Tandem Diabetes Care existing price patterns will revert.



Weak predictability

Tandem Diabetes Care has weak predictability. Overlapping area represents the amount of predictability between Tandem Diabetes time series from 1st of February 2024 to 16th of February 2024 and 16th of February 2024 to 2nd of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tandem Diabetes Care price movement. The serial correlation of 0.21 indicates that over 21.0% of current Tandem Diabetes price fluctuation can be explain by its past prices.
Correlation Coefficient0.21
Spearman Rank Test-0.03
Residual Average0.0
Price Variance4.41

Tandem Diabetes Care lagged returns against current returns

Autocorrelation, which is Tandem Diabetes stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tandem Diabetes' stock expected returns. We can calculate the autocorrelation of Tandem Diabetes returns to help us make a trade decision. For example, suppose you find that Tandem Diabetes stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   

Tandem Diabetes regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tandem Diabetes stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tandem Diabetes stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tandem Diabetes stock over time.
   Current vs Lagged Prices   

Tandem Diabetes Lagged Returns

When evaluating Tandem Diabetes' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tandem Diabetes stock have on its future price. Tandem Diabetes autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tandem Diabetes autocorrelation shows the relationship between Tandem Diabetes stock current value and its past values and can show if there is a momentum factor associated with investing in Tandem Diabetes Care.
   Regressed Prices   

Tandem Diabetes Investors Sentiment

The influence of Tandem Diabetes' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tandem. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tandem Diabetes' public news can be used to forecast risks associated with an investment in Tandem. The trend in average sentiment can be used to explain how an investor holding Tandem can time the market purely based on public headlines and social activities around Tandem Diabetes Care. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tandem Diabetes' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tandem Diabetes' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tandem Diabetes' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tandem Diabetes.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tandem Diabetes in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tandem Diabetes' short interest history, or implied volatility extrapolated from Tandem Diabetes options trading.

Currently Active Assets on Macroaxis

When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:
Check out Tandem Diabetes Correlation, Tandem Diabetes Volatility and Tandem Diabetes Alpha and Beta module to complement your research on Tandem Diabetes.
Note that the Tandem Diabetes Care information on this page should be used as a complementary analysis to other Tandem Diabetes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Tandem Stock analysis

When running Tandem Diabetes' price analysis, check to measure Tandem Diabetes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tandem Diabetes is operating at the current time. Most of Tandem Diabetes' value examination focuses on studying past and present price action to predict the probability of Tandem Diabetes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tandem Diabetes' price. Additionally, you may evaluate how the addition of Tandem Diabetes to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Tandem Diabetes technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tandem Diabetes technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tandem Diabetes trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...